Matches in Nanopublications for { ?s ?p "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP484899.RADt4CMtdS8FH6z-GnL7BSeepLxWQ05qQ4vlbM0DP0yoc130_assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484899.RADt4CMtdS8FH6z-GnL7BSeepLxWQ05qQ4vlbM0DP0yoc130_provenance.
- NP1119697.RAgafHUs6MGDXJJSzLwNzvEb6NrVnpaHjRPnzvARBdUN8130_assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119697.RAgafHUs6MGDXJJSzLwNzvEb6NrVnpaHjRPnzvARBdUN8130_provenance.
- NP484849.RAw8MNmQ1SxrqJtl7gSSfwlgOD9xfzdk-96JHg-R8didY130_assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484849.RAw8MNmQ1SxrqJtl7gSSfwlgOD9xfzdk-96JHg-R8didY130_provenance.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.